Mousallem, T., Urban, T. J., Roberts, J. L., Parrott, R. E., Goldstein, D. B., & Buckley, R. H. (2013). Next Generation Sequencing May Be More Efficient and Economical Than Targeted Gene Testing in Patients with Primary Immune Deficiency (PID). In Journal of Allergy and Clinical Immunology (Vol. 131, pp. AB52–AB52). Elsevier BV. https://doi.org/10.1016/j.jaci.2012.12.870

Mousallem, Talal, Thomas J. Urban, Joseph L. Roberts, Roberta E. Parrott, David B. Goldstein, and Rebecca H. Buckley. “Next Generation Sequencing May Be More Efficient and Economical Than Targeted Gene Testing in Patients with Primary Immune Deficiency (PID).” In Journal of Allergy and Clinical Immunology, 131:AB52–AB52. Elsevier BV, 2013. https://doi.org/10.1016/j.jaci.2012.12.870.

Mousallem T, Urban TJ, Roberts JL, Parrott RE, Goldstein DB, Buckley RH. Next Generation Sequencing May Be More Efficient and Economical Than Targeted Gene Testing in Patients with Primary Immune Deficiency (PID). In: Journal of Allergy and Clinical Immunology. Elsevier BV; 2013. p. AB52–AB52.

Mousallem, Talal, et al. “Next Generation Sequencing May Be More Efficient and Economical Than Targeted Gene Testing in Patients with Primary Immune Deficiency (PID).” Journal of Allergy and Clinical Immunology, vol. 131, no. 2, Elsevier BV, 2013, pp. AB52–AB52. Crossref, doi:10.1016/j.jaci.2012.12.870.

Mousallem T, Urban TJ, Roberts JL, Parrott RE, Goldstein DB, Buckley RH. Next Generation Sequencing May Be More Efficient and Economical Than Targeted Gene Testing in Patients with Primary Immune Deficiency (PID). Journal of Allergy and Clinical Immunology. Elsevier BV; 2013. p. AB52–AB52.